Garelnabi M - Search Results

1

Exercise might favor reverse cholesterol transport and lipoprotein clearance: potential mechanism for its anti-atherosclerotic effects.

Wei C, Penumetcha M, Santanam N, Liu YG, Garelnabi M, Parthasarathy S. Wei C, et al. Among authors: garelnabi m. Biochim Biophys Acta. 2005 May 25;1723(1-3):124-7. doi: 10.1016/j.bbagen.2005.03.005. Epub 2005 Mar 22. Biochim Biophys Acta. 2005. PMID: 15820521

2

Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability.

Parthasarathy S, Litvinov D, Selvarajan K, Garelnabi M. Parthasarathy S, et al. Among authors: garelnabi m. Biochim Biophys Acta. 2008 May;1781(5):221-31. doi: 10.1016/j.bbalip.2008.03.002. Epub 2008 Mar 25. Biochim Biophys Acta. 2008. PMID: 18406361 Free PMC article. Review.

3

Targeting the Role of Lipoprotein (a) in Stroke.

Mazhar Z, Hughes A, Garelnabi M. Mazhar Z, et al. Among authors: garelnabi m. Cardiovasc Hematol Disord Drug Targets. 2017;17(1):64-72. doi: 10.2174/1871529X17666170421150028. Cardiovasc Hematol Disord Drug Targets. 2017. PMID: 28429674 Review.

4

Oxidized low-density lipoprotein.

Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N. Parthasarathy S, et al. Methods Mol Biol. 2010;610:403-17. doi: 10.1007/978-1-60327-029-8_24. Methods Mol Biol. 2010. PMID: 20013192 Free PMC article. Review.

5

Alpha-tocopherol is ineffective in preventing the decomposition of preformed lipid peroxides and may promote the accumulation of toxic aldehydes: a potential explanation for the failure of antioxidants to affect human atherosclerosis.

Raghavamenon A, Garelnabi M, Babu S, Aldrich A, Litvinov D, Parthasarathy S. Raghavamenon A, et al. Among authors: garelnabi m. Antioxid Redox Signal. 2009 Jun;11(6):1237-48. doi: 10.1089/ars.2008.2248. Antioxid Redox Signal. 2009. PMID: 19186999 Free PMC article.

6

Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice.

Litvinov D, Selvarajan K, Garelnabi M, Brophy L, Parthasarathy S. Litvinov D, et al. Among authors: garelnabi m. Atherosclerosis. 2010 Apr;209(2):449-54. doi: 10.1016/j.atherosclerosis.2009.09.076. Epub 2009 Oct 12. Atherosclerosis. 2010. PMID: 19880116 Free PMC article.

7

Dietary oxidized linoleic acid lowers triglycerides via APOA5/APOClll dependent mechanisms.

Garelnabi M, Selvarajan K, Litvinov D, Santanam N, Parthasarathy S. Garelnabi M, et al. Atherosclerosis. 2008 Aug;199(2):304-9. doi: 10.1016/j.atherosclerosis.2007.12.026. Epub 2008 Feb 20. Atherosclerosis. 2008. PMID: 18243209 Free PMC article.

8

Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress.

Garelnabi MO, Brown WV, Le NA. Garelnabi MO, et al. Clin Biochem. 2008 Oct;41(14-15):1250-4. doi: 10.1016/j.clinbiochem.2008.07.009. Epub 2008 Jul 30. Clin Biochem. 2008. PMID: 18703037

9

The emerging role of outdoor and indoor air pollution in cardiovascular disease.

Uzoigwe JC, Prum T, Bresnahan E, Garelnabi M. Uzoigwe JC, et al. Among authors: garelnabi m. N Am J Med Sci. 2013 Aug;5(8):445-53. doi: 10.4103/1947-2714.117290. N Am J Med Sci. 2013. PMID: 24083218 Free PMC article. Review.

10

Berberine Encapsulated PLGA-PEG Nanoparticles Modulate PCSK-9 in HepG2 Cells.

Ochin CC, Garelnabi M. Ochin CC, et al. Among authors: garelnabi m. Cardiovasc Hematol Disord Drug Targets. 2018;18(1):61-70. doi: 10.2174/1871529X18666180201130340. Cardiovasc Hematol Disord Drug Targets. 2018. PMID: 29422010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results